___

• 1. Bostjancic E, Zidar N, Stajer D, Glavac D. “MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction”, Cardiology. 2010;115:163-9. 2. Cerda A, Fajardo CM, Basso RG, Hirata MH, Hirata RD. Role of microRNAs 221/222 on statin induced nitric oxide release in human endothelial cells. Arq Bras Cardiol. 2015;104:195-201. 3. Chen WM, Sheu WH, Tseng PC, Lee TS, Lee WJ, Chang PJ, Chiang AN. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins. PLoS One. 2016;11:e0154672. 4. Coffey S, Williams MJ, Phillips LV, Galvin IF, Bunton RW, Jones GT. Integrated microRNA and messenger RNA analysis in aortic stenosis. Sci Rep. 2016;6:36904. 5. Dong X, Xu M, Ren Z, Gu J, Lu M, Lu Q, Zhong N. Regulation of CBL and ESR1 expression by microRNA-22‑3p, 513a-5p and 625-5p may impact the pathogenesis of dust mite- induced pediatric asthma. Int J Mol Med. 2016;38:446-56. 6. Elrod JW & Lefer DJ. The effects of statins on endothelium, inflammation and cardioprotection. Drug News Perspect 2005;18:229– 236. 7. Fazi F, Nervi C. MicroRNA: basic mechanisms and transcriptional regulatory Networks for cell fate determination, Cardiovasc Res, 2008;79:553–561. 8. Gits CM, van Kuijk PF, de Rijck JC, Muskens N, Jonkers MB, van IJcken WF, Mathijssen RH, Verweij J, Sleijfer S, Wiemer EA. MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α. BMC Cancer. 2014;14:429. 9. Gopalan V, Smith RA, Lam AK. Downregulation of microRNA-498 in colorectal cancers and its cellular effects. Exp Cell Res. 2015;330:423-8. 10. Han H, Qu G, Han C, Wang Y, Sun T, Li F, Wang J, Luo S.MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort, Exp Mol Med, 2015;6:47,e138. 11. Hardie DG, Carling D & Carlson M. The AMPactivated/ SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998;67: 821–855 12. Haver VG, Slart RH, Zeebregts CJ, Peppelenbosch MP, Tio RA. Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra?, Trends Cardiovasc Med 2010;20:65-71. 13. Jiang Y, Wang HY, Cao HM, Wang CY, Zhang L, Wang H, Liu L, Li Y, Cai JH. Peripheral blood miRNAs as a biomarker for chronic cardiovascular disease, Sci Rep, 2014;22:4-5026. 14. Motoshima H, Goldstein BJ, Igata M, Araki E. AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol. 2006; 574:63-71. 15. Nathan Wong and Xiaowei Wang miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Research. 2015;43:46-152. 16. Niesor EJ, Schwartz GG, Perez A, Stauffer A, Durrwell A, Bucklar-Suchankova G, Benghozi R, Abt M, Kallend D. Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein. Cardiovasc Drugs Ther. 2015;29:7-14. 17. Nouraee N, Mowla SJ. miRNA therapeutics in cardiovascular diseases: promises and problems. Front Genet 2015;30;6:232. 18. Raitoharju E, Lyytikäinen LP, Levula M, Oksala N, Mennander A, Tarkka M, Klopp N, Illig T, Kähönen M, Karhunen PJ, Laaksonen R, Lehtimäki T. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study”,Atherosclerosis, 2011;219:211-7 19. Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res, 2009;82:21–29. 20. Satoh M, Tabuchi T, Minami Y, Takahashi Y, Itoh T, Nakamura M. Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal. Immunobiology. 2012;217:533-9. 21. Scalbert E, Bril A. Implication of microRNAs in the cardiovascular system. Curr Opin Pharmacol. 2008 ;8:181-8. 22. Strandberg, T.E., Vanhanen, H., Tikkanen, M.J. Effect of statins on C-reactive protein in patients with coronary artery disease. Lancet 1999;353:118–119. 23. Syed Salman A, Chandra Kala, Mohd Abid1, Nabeel Ahmad, Uma Shankar Sharma, Najam Ali Khan Pathological microRNAs in acute cardiovascular diseases and microRNA therapeutics. J. Acute Dis. 2016;5:9–15 24. Tabuchi T, Satoh M, Itoh T, Nakamura M. MicroRNA- 34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Clin Sci (Lond). 2012;123:161-71. 25. Van Rooij E, Sutherland LB, Thatcher JE, Di-Maio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis, Proc Natl Acad Sci USA, 2008;105:3027–13032. 26. Wang F, Long G, Zhao C, Li H, Chaugai S, Wang Y, Chen C, Wang DW. Atherosclerosis- related circulating miRNAs as novel and sensitive predictors for acute myocardial infarction, PLoS One, 2014;3:9-e105734. 27. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2,Nat Med, 2007;13:486– 491. 28. Yin C, Wang X, Kukreja RC. Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemiareperfusion in mice, FEBS Lett, 2008;582:4137–4142.